Atossa Genetics Inc.

Available to platforms
R StocksTrader
Atossa Genetics Inc. (ATOS) is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for breast cancer and other breast-related health conditions. Headquartered in Seattle, Washington, Atossa leverages advanced technologies to address unmet medical needs in oncology and women's health. The company’s key programs include drug candidates like (Z)-endoxifen, aimed at preventing and treating breast cancer, and other targeted therapies for improving patient outcomes. Atossa Genetics is committed to advancing precision medicine and delivering groundbreaking treatments that can enhance the quality of care for patients worldwide.

Atossa Genetics Inc. (ATOS) on the NASDAQ Exchange

Company overview

Atossa Genetics Inc. is a publicly listed company from USA with shares traded on NASDAQ under the ticker ATOS. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for ATOS are bid 0.8 USD and ask 0.83 USD.

Use the chart to review recent momentum, identify key price areas, and track how Atossa Genetics Inc. is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add ATOS to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NASDAQ
  • Company: Atossa Genetics Inc.
  • Ticker: ATOS
  • Country: USA
  • Bid0.8 USD
  • Ask0.83 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of ATOS does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Atossa Genetics Inc. (ATOS) in R StocksTrader. Create and verify your profile, fund the account, search for ATOS, and choose the instrument type available to you. Add ATOS to your Watchlist to track moves and manage open positions throughout 2025.

ATOS trades on NASDAQ and is issued by Atossa Genetics Inc.. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for ATOS match your plan.

Quotes update automatically in real time. Current levels for ATOS are bid 0.8 USD and ask 0.83 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track ATOS in R StocksTrader and adjust your approach as market conditions change in 2025.